Filing Details
- Accession Number:
- 0001209191-23-027314
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-05-04 16:03:53
- Reporting Period:
- 2023-04-03
- Accepted Time:
- 2023-05-04 16:03:53
- Original Submission Date:
- 2023-04-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1851194 | Ventyx Biosciences Inc. | VTYX | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1394208 | W Christopher Krueger | C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd, Suite 250 Encinitas CA 92024 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-03 | 7,972 | $3.54 | 290,642 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 475 | $8.04 | 291,117 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 15,000 | $32.88 | 276,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- This amendment is being filed to correct the transaction date reported in the Form 4 filed April 5, 2023.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
- Represents the weighted average share price of an aggregate total of 15,000 shares sold in the price range of $32.5744 to $33.495. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
